Related Experiment Video
Updated: Jun 14, 2026
Adult and Pediatric Porcine Model of Acute Volume Overload
Published on: January 12, 2024
Vasopressin in the pediatric cardiac intensive care unit: Myth or reality
Vishal K Singh1, Rajesh Sharma, Amit Agrawal
1Escorts Heart Institute and Research Center, Okhla Road, New Delhi, India.
Insights
Vasopressin, a drug used in adults for over a decade, is now a valuable tool for treating shock in critically ill children undergoing cardiac surgery. This review explores its physiology and application in pediatric care.
Area of Science:
- Cardiology
- Pediatric Critical Care
- Pharmacology
Background:
- Pediatric cardiac surgery is increasingly complex, involving more critically ill patients.
- Advances in critical care necessitate updated knowledge of pharmacologic interventions.
- Effective management of shock in pediatric patients requires understanding novel therapeutic agents.
Purpose of the Study:
- To review the physiological mechanisms of vasopressin.
- To examine the rationale for using vasopressin in pediatric shock.
- To synthesize available data on vasopressin's efficacy in critically ill children.
Main Methods:
- Literature review of published data on vasopressin.
- Analysis of vasopressin's physiological effects relevant to pediatric shock.
- Synthesis of evidence regarding vasopressin use in pediatric cardiac surgery patients.
Main Results:
- Vasopressin exhibits unique vasoconstrictive properties distinct from catecholamines.
- Emerging data support its role in refractory shock when conventional therapies fail.
- Its use in pediatric patients is expanding based on adult data and early pediatric studies.
Conclusions:
- Vasopressin offers a potential therapeutic option for managing shock in critically ill pediatric cardiac surgery patients.
- Further research is warranted to fully elucidate its role and optimize its use in this population.
- Understanding vasopressin's physiology is crucial for its effective application in pediatric intensive care settings.
Abstract:
Pediatric cardiac surgery is undergoing a metamorphosis, with more and more critical patients being operated in our country today. Although the principles of physiology have not changed, it is imperative that care providers continue to stay abreast with developments and newer drugs that may help modify the outcome. The team dynamics have also become more complex, which necessitates the need for all care providers (surgeons, cardiologists, anesthesiologists, and intensivists) to better understand the interactions and benefits of newer drugs. Vasopressin has been used in our adult patients for more than a decade and recently has found its rightful place in the pediatric armoury. The objective of this article is to review the physiology of vasopressin and the rationale of its use in critically ill children with shock, in context of the available published data.
Related Concept Videos
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
01:27Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management